Testing in a Pandemic — Improving Access, Coordination, and Prioritization

The enormous U.S. toll of Covid-19 is attributable in part to the lack of an effective testing regimen. But by building distributed capacity and prioritizing resources appropriately, we can change our trajectory in fighting this pandemic and preempting future ones.

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 384; no. 3; pp. 197 - 199
Main Authors Botti-Lodovico, Yolanda, Rosenberg, Eric, Sabeti, Pardis C
Format Journal Article
LanguageEnglish
Published United States Massachusetts Medical Society 21.01.2021
Subjects
Asymptomatic
Coronaviruses
COVID-19
COVID-19 - diagnosis
COVID-19 Testing
Diagnostic Test Approval - legislation & jurisprudence
Disease transmission
Emergency preparedness
FDA approval
Financing, Government
Government Regulation
Health Policy
Humans
Laboratories - economics
Laboratories - organization & administration
Leadership
Medical laboratories
Pandemics
Polymerase Chain Reaction
Production capacity
Public health
R&D
Research & development
Research Support as Topic
Severe acute respiratory syndrome coronavirus 2
Surveillance
United States
United States Food and Drug Administration
United States
United States > US
Online AccessGet full text

Cover

More Information
Summary:The enormous U.S. toll of Covid-19 is attributable in part to the lack of an effective testing regimen. But by building distributed capacity and prioritizing resources appropriately, we can change our trajectory in fighting this pandemic and preempting future ones.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMp2025173